61.55% of Foghorn Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Foghorn Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/22/2024	Rockwood Wealth Management LLC	107,329	$0.72M	0.1%	-50.0%	0.252%
4/22/2024	Raymond James & Associates	2,230,456	$14.97M	0.0%	+7.8%	5.240%
2/15/2024	Birchview Capital LP	320,930	$2.07M	1.6%	+21.2%	0.760%
2/12/2024	Alta Wealth Advisors LLC	30,032	$0.19M	0.1%	N/A	0.071%
2/8/2024	Panagora Asset Management Inc.	97,017	$0.63M	0.0%	+180.6%	0.230%
1/25/2024	Nisa Investment Advisors LLC	5,000	$32K	0.0%	+788.1%	0.012%
1/16/2024	Raymond James & Associates	2,068,387	$13.34M	0.0%	+45.0%	4.899%
1/5/2024	Exchange Traded Concepts LLC	21,535	$0.14M	0.0%	+34.0%	0.051%
11/13/2023	FMR LLC	2,898,219	$14.49M	0.0%	-0.3%	6.865%
10/31/2023	Panagora Asset Management Inc.	34,576	$0.17M	0.0%	N/A	0.083%
10/24/2023	Raymond James & Associates	1,426,226	$7.13M	0.0%	+19.8%	3.407%
9/21/2023	Barclays PLC	4,071	$29K	0.0%	-59.8%	0.010%
7/25/2023	Raymond James & Associates	1,190,989	$8.39M	0.0%	+10.5%	2.847%
7/20/2023	Exchange Traded Concepts LLC	16,471	$0.12M	0.0%	N/A	0.039%
5/15/2023	Affinity Asset Advisors LLC	136,771	$0.85M	0.3%	+24.3%	0.327%
4/14/2023	Raymond James & Associates	1,078,056	$6.68M	0.0%	+97.8%	2.579%
2/13/2023	Cornercap Investment Counsel Inc.	26,163	$0.17M	0.0%	N/A	0.063%
2/10/2023	Wade G W & Inc.	107,770	$0.69M	0.0%	N/A	0.258%
2/8/2023	Raymond James & Associates	544,933	$3.48M	0.0%	+1,770.2%	1.304%
11/28/2022	Birchview Capital LP	264,843	$2.27M	1.6%	-7.0%	0.634%
11/16/2022	Alphabet Inc.	500,901	$4.30M	0.2%	N/A	1.198%
11/14/2022	Point72 Asset Management L.P.	388,600	$3.33M	0.0%	+3.4%	0.930%
11/7/2022	Birchview Capital LP	264,843	$2.27M	1.6%	-7.0%	0.636%
11/2/2022	Victory Capital Management Inc.	37,500	$0.32M	0.0%	N/A	0.090%
8/16/2022	Deerfield Management Company L.P. Series C	777,525	$10.57M	0.2%	+225.5%	1.867%
8/16/2022	Driehaus Capital Management LLC	382,940	$5.21M	0.1%	+19.7%	0.920%
8/15/2022	Point72 Asset Management L.P.	376,000	$5.11M	0.0%	+7,130.8%	0.903%
8/12/2022	Virtus ETF Advisers LLC	8,198	$0.11M	0.0%	N/A	0.020%
8/12/2022	FMR LLC	3,433,878	$46.70M	0.0%	+7.4%	8.247%
8/9/2022	TIAA FSB	14,469	$0.20M	0.0%	N/A	0.035%
8/5/2022	State Board of Administration of Florida Retirement System	12,474	$0.17M	0.0%	N/A	0.030%
7/21/2022	Wedbush Securities Inc.	10,192	$0.14M	0.0%	N/A	0.025%
6/30/2022	Amalgamated Bank	2,501	$38K	0.0%	N/A	0.006%
5/16/2022	Deerfield Management Company L.P. Series C	238,865	$3.64M	0.1%	N/A	0.576%
5/16/2022	J. Goldman & Co LP	25,488	$0.39M	0.0%	+36.0%	0.061%
5/10/2022	NewSquare Capital LLC	10,000	$0.15M	0.0%	N/A	0.024%
2/15/2022	Kingdon Capital Management L.L.C.	54,341	$1.24M	0.1%	-73.6%	0.147%
2/14/2022	Point72 Asset Management L.P.	383,472	$8.77M	0.0%	N/A	1.034%
2/11/2022	EAM Global Investors LLC	103,241	$2.36M	0.4%	N/A	0.278%
2/9/2022	WASHINGTON TRUST Co	1,500	$34K	0.0%	N/A	0.004%
2/8/2022	Raymond James & Associates	12,937	$0.30M	0.0%	N/A	0.035%
2/8/2022	Northern Trust Corp	170,476	$3.90M	0.0%	-2.6%	0.460%
2/7/2022	SG Americas Securities LLC	4,624	$0.11M	0.0%	-57.7%	0.012%
2/7/2022	Monashee Investment Management LLC	240,000	$5.49M	1.4%	-54.8%	0.647%
11/16/2021	Metropolitan Life Insurance Co NY	6,569	$92K	0.0%	N/A	0.018%
11/16/2021	Casdin Capital LLC	215,000	$3M	0.1%	-0.6%	0.580%
11/15/2021	Pura Vida Investments LLC	68,095	$0.95M	0.0%	N/A	0.184%
11/15/2021	Morgan Stanley	979,227	$13.64M	0.0%	-0.1%	2.640%
11/15/2021	Kingdon Capital Management L.L.C.	205,741	$2.87M	0.3%	N/A	0.555%
11/12/2021	Geode Capital Management LLC	272,707	$3.80M	0.0%	+14.7%	0.738%
11/10/2021	Citigroup Inc.	2,231	$31K	0.0%	+139.9%	0.006%
11/9/2021	BlackRock Inc.	1,119,685	$15.60M	0.0%	+2.4%	3.031%
11/4/2021	Deutsche Bank AG	94,940	$1.32M	0.0%	-49.8%	0.257%
11/2/2021	New York State Common Retirement Fund	13,701	$0.19M	0.0%	-18.2%	0.037%
11/1/2021	SG Americas Securities LLC	10,925	$0.15M	0.0%	N/A	0.030%
8/17/2021	Millennium Management LLC	195,762	$2.09M	0.0%	+20.8%	0.530%
8/16/2021	California State Teachers Retirement System	26,977	$0.29M	0.0%	+148.0%	0.073%
8/16/2021	Morgan Stanley	980,209	$10.46M	0.0%	+149.0%	2.654%
8/16/2021	Charles Schwab Investment Management Inc.	71,361	$0.76M	0.0%	+49.9%	0.193%
8/16/2021	State Street Corp	189,399	$2.02M	0.0%	+73.6%	0.513%
8/16/2021	Nuveen Asset Management LLC	56,410	$0.60M	0.0%	+377.8%	0.153%
8/13/2021	Northern Trust Corp	162,900	$1.74M	0.0%	+93.2%	0.441%
8/13/2021	Geode Capital Management LLC	237,744	$2.54M	0.0%	+62.1%	0.645%
8/13/2021	Vanguard Group Inc.	683,778	$7.30M	0.0%	+67.9%	1.856%
8/13/2021	FMR LLC	2,540,434	$27.11M	0.0%	-1.3%	6.895%
8/12/2021	JPMorgan Chase & Co.	26,235	$0.28M	0.0%	+31.1%	0.071%
8/11/2021	Bank of New York Mellon Corp	51,419	$0.55M	0.0%	+164.5%	0.140%
8/11/2021	BlackRock Inc.	1,093,860	$11.67M	0.0%	+153.1%	2.969%
8/11/2021	Deutsche Bank AG	189,109	$2.02M	0.0%	-15.2%	0.513%
8/5/2021	Rhumbline Advisers	15,659	$0.17M	0.0%	N/A	0.042%
8/2/2021	New York State Common Retirement Fund	16,758	$0.18M	0.0%	+308.7%	0.045%
5/19/2021	Octagon Capital Advisors LP	69,132	$0.91M	0.3%	N/A	0.188%
5/18/2021	Millennium Management LLC	162,118	$2.14M	0.0%	-24.5%	0.440%
5/18/2021	Point72 Asset Management L.P.	109,200	$1.44M	0.0%	N/A	0.296%
5/18/2021	Morgan Stanley	393,722	$5.19M	0.0%	+821.1%	1.069%
5/17/2021	Suvretta Capital Management LLC	84,000	$1.11M	0.0%	-67.5%	0.228%
5/14/2021	Monashee Investment Management LLC	530,581	$6.99M	1.1%	-5.3%	1.441%
5/13/2021	Bank of New York Mellon Corp	19,440	$0.26M	0.0%	+7.5%	0.053%
5/12/2021	Northern Trust Corp	84,296	$1.11M	0.0%	-4.7%	0.229%
5/12/2021	Geode Capital Management LLC	146,640	$1.93M	0.0%	+10.7%	0.398%
5/7/2021	BlackRock Inc.	432,125	$5.70M	0.0%	-35.7%	1.173%
5/4/2021	Victory Capital Management Inc.	16,190	$0.21M	0.0%	-82.6%	0.044%
3/26/2021	Susquehanna International Group LLP	27,939	$0.57M	0.0%	N/A	0.076%
2/25/2021	Hsbc Holdings PLC	18,900	$0.39M	0.0%	N/A	0.053%
2/19/2021	JPMorgan Chase & Co.	19,639	$0.40M	0.0%	N/A	0.055%
2/16/2021	Flagship Pioneering Inc.	12,674,120	$256.91M	4.7%	N/A	35.389%
2/16/2021	Nuveen Asset Management LLC	11,807	$0.24M	0.0%	N/A	0.033%
2/16/2021	Charles Schwab Investment Management Inc.	45,956	$0.93M	0.0%	N/A	0.128%
2/13/2021	American International Group Inc.	4,181	$85K	0.0%	N/A	0.012%
2/12/2021	Caas Capital Management LP	15,000	$0.30M	0.0%	N/A	0.042%
2/11/2021	Northern Trust Corp	88,438	$1.79M	0.0%	N/A	0.247%
2/11/2021	Citigroup Inc.	1,329	$27K	0.0%	N/A	0.004%
2/11/2021	Artal Group S.A.	1,720,720	$34.88M	0.7%	N/A	4.805%
2/11/2021	Monashee Investment Management LLC	560,360	$11.36M	1.5%	N/A	1.565%
2/10/2021	Board of Trustees of The Leland Stanford Junior University	30,657	$0.62M	0.0%	N/A	0.086%
2/9/2021	Wells Fargo & Company MN	3,747	$76K	0.0%	N/A	0.010%
2/9/2021	Bank of New York Mellon Corp	18,086	$0.37M	0.0%	N/A	0.050%
2/8/2021	New York State Common Retirement Fund	4,100	$83K	0.0%	N/A	0.011%
2/5/2021	BlackRock Inc.	672,204	$13.63M	0.0%	N/A	1.877%
2/1/2021	Victory Capital Management Inc.	93,070	$1.89M	0.0%	N/A	0.260%

Data available starting January 2016

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It develops FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM that is in phase I for the treatment of relapsed and/or refractory acute myeloid leukemia/myelodysplastic syndrome. The company is also developing therapies for mutant cancers, such as Non-Small Cell Lung, bladder, endometrial, colorectal, and melanoma cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $5.21

$5.15

$5.62

50 Day Range

MA: $6.56

$5.05

$8.00

52 Week Range

Now: $5.21

$2.70

$9.97

Volume

111,112 shs

Average Volume

150,155 shs

Market Capitalization

$221.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.13

Who are the company insiders with the largest holdings of Foghorn Therapeutics?: Foghorn Therapeutics' top insider investors include:
Samuel Agresta (Insider)
Learn More about top insider investors at Foghorn Therapeutics.
Who are the major institutional investors of Foghorn Therapeutics?: Foghorn Therapeutics' top institutional investors include:
Raymond James & Associates — 5.24%
Rockwood Wealth Management LLC — 0.25%
Learn More about top institutional investors of Foghorn Therapeutics stock.
Which major investors are selling Foghorn Therapeutics stock?: Within the previous quarter, FHTX stock was sold by these institutional investors:
Rockwood Wealth Management LLC
Which major investors are buying Foghorn Therapeutics stock?: Within the previous quarter, FHTX stock was acquired by institutional investors including:
Raymond James & Associates